CsA decreases renal host resistance to UPEC. by Emilie Tourneur (278826)

Inhibition of Hsp90 decreased cellular apoptosis. by Raúl Orozco-Díaz (7067624)

Homocysteine decreases G9a expression both <i>in vitro</i> and <i>in vivo</i>. by Wenjing Lei (772749)

Hcy decreased the binding of G9a to the <i>COL1A1</i> promoter. by Wenjing Lei (772749)

Decrease in Vitamin D Status in the Greenlandic Adult Population from 1987–2010 by Nina O. Nielsen (490187)

“…Age (2.0% per year increase; CI: 1.7, 2.2), female gender (7.1%; CI: 2.0; 12.5), alcohol intake (0.2% per increase in drinks/week; 0.0; 0.4), and traditional diet (10.0% per 100 g/d increase; CI: 7.9; 12.1) were associated with increased serum 25(OH)D3, whereas smoking (−11.6%; CI: −16.2; −6.9), BMI (−0.6%; CI: −1.1; −0.2) and latitude (−0.7% per degree increase; CI: −1.3; −0.2) were associated with decreased concentrations.…”

Mice carrying 100P mutations show layer-specific decreases in proportions of PV+ cells. by Malgorzata Borkowska (3166719)

“…<p>(<b>A-D</b>) Decreases occurred in layer IV in fSSp, SSp, vAud and Vis, in layer V in SSp, vAud and Vis and in layer II/III in SSp. …”

Aspirin-Triggered Resolvin D1 Attenuated IL-1β-mediated leukocyte-epithelial cell adhesion. by Ruan Cox Jr. (789575)

Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial by José Tarcisio G. Carvalho (4217248)

“…In the clinical trial, thirty-two (32) dialysis patients with 25 vitamin D ≤ 20ng/mL were randomized to receive either supplementation of cholecalciferol 100,000 UI/week/3 months (16 patients) or placebo (16 patients). …”

GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

Subjects:

Grb2 silencing decreases phagocytic uptake in RPE cells. by Shameka J. Shelby (279119)

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…(E) ATRA and clodronate liposome treatment, composite from 2 sections. Scale bar: 100 μm in A and B. (F) Bar and scatter plots of the number of axons per transverse section, sampled at approximately 200 μm distal to the cut site, showing mean ± SEM. …”

Resveratrol treatment decreases SIRT1 and SIRT2 levels. by Mehtap Kilic Eren (591048)

CyaA decreases the capacity of TLR-stimulated DCs to present soluble antigen to CD4⁺ T cells. by Irena Adkins (173166)

Decoy Wnt receptor sLRP6E1E2 decreases proliferation in human lung cancer cells. by Jung-Sun Lee (164985)

Removal of the A-B linker did not decrease PIP₂ affinity. <i>A.-</i> by Paloma Aivar (124885)

Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells. by Malgorzata Borkowska (3166719)

“…(<b>C</b>) There were no corresponding changes in the proportions of GAD67+ cells. (<b>D</b>, <b>E</b>) No major change was observed in the proportion of cells expressing calretinin (CLR) or somatostatin (STT) across the mutant cortex (n = 3–8 animals for each comparison; data are means ± sems; * p<0.05, ** p<0.01, two-way ANOVA with Dunnet’s multiple comparisons test where applicable). …”

Loss of Abl kinase function decreased endothelial barrier dysfunction <i>in</i><i>vitro</i>. by Elizabeth M. Chislock (499669)

MCM-BP can decrease phosphorylation by DDK but is not a substrate. by Tin Nguyen (231591)

Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

“…These mice exhibited a minimal change in noise-evoked PPy activity when comparing the first and second week of imaging (2-way ANOVA, F = 1.79, <i>p</i> = 0.11, post hoc baseline w1 50 dB: baseline w2 50 dB <i>p</i> = 1 Bonferroni corrected, nested ANOVA (mouse nested within session) F = 1.76, <i>p</i> = 0.12, mean ± SE). …”

The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

“…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”